Pier Paolo Piccaluga
University of Bologna, Italy
Associate Professor, Department of Experimental, Diagnostic and Specialty Medicine – DIMES
Academic discipline: MED/08 Pathology
2012 – present – Associate Professor & Executive Physician, Department of Experimental, Diagnostic and Specialty Medicine – Institute of Hematology and Medical Oncology, Bologna University, S. Orsola Malpighi Hospital, Bologna, Italy
▪ PI for Genomic and Personalized Medicine Research Group
▪ Main clinical interest: role of viruses in tumorigenesis, molecular diagnostics
2020 – Adjunct Professor, Botswana University, Gaborone (Botswana)
2019 – Visiting Professor, Nairobi University, Nairobi (Kenya)
2018 – present – Adjunct Professor of Hematology and Pathology at Jomo Kenyatta University of Agricolture and Technology, Nairobi, Kenya
▪ Teaching at Medical School (100%)
2018-present – Temporary Professor, Queen Mary University of London, London, UK, Joint Program with Nanchang University
2017-present – Member of the Scientific Committee, Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy
2014-present: National Academic Qualification as Full Professor of Pathology
2019-present: National Academic Qualification as Full Professor of Hematology/Oncology/Rheumatology as well as of Science of Medical Professionals and Medical Technologies
2006-2012: Lecturer/Assitant Professor & Executive physician, Institute of hematology and Medical Oncology, Bologna University, S. Orsola Malpighi Hospital, Bologna, Italy
▪ Teaching at Medical School (33%), Research (33%), Clinical duties (34%)
▪ PI for a molecular biology laboratory; responsible for molecular diagnostics
2009: Invited Visiting Scientist, Institut fur Pathologie, Università di Kiel, Germany. Revision of professor Karl Lennert personal archive including about 10,000 hematopathological cases
2017: Invited Visiting Physician, Nairobi Hospital and Kenyatta Hospital, Nairobi University Clinical Oncohematology Unit (clinical cases discussion and teaching)
Significant contribution to the definition of peripheral T-cell lymphomas molecular pathogenesis
Significant contribution to the definition of Burkitt lymphoma pathogenesis and EBV impact on Burkitt lymphoma
Identification of molecular signatures predictive of treatment response in patients affected by acute leukemias
Development of novel molecular diagnostic tools (3 currently patented)
Set up of new laboratories for molecular diagnostic and research
Selected for Top Italian Scientist ranking
Development of European guidelines for acute lymphoid leukemia diagnosis and treatment
Current interests and objectives
Definition of viral contribution to human lymphoma pathogenesis
Development of novel tools for molecular diagnositics
Development of a telemedicine service serving several African hospitals
COVID-19 pathogenesis and diagnosis
Author of several presentations at national and international conferences.
Involved in several clinical trials as coordinator or sub-investigator.
Winner of several prizes for study and research.
Involved/PI in several research project granted by national and international recognized organisms.
Invited referee for several Journals indexed in the Current Contents.
Associate Editor for the American Journal of Blood Research, Case reports in Medicine, Frontiers in Molecular
Biosciences, Helyon, Journal of Torbat Heydariyeh University of Medical Sciences.
Already member of the following societies: SIE, SIES, ASH, AACR, SIAPEC/IAP, EHA, ELN/EWALL, FIL